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project brief

INTRODUCTION OF DMPA IN PUBLIC HEALTH
FACILITIES OF UTTAR PRADESH AND
RAJASTHAN: AN EVALUATION

BACKGROUND
India is committed to achieving the goals of Family Planning
2020 (FP2020), which, besides substantially increasing new
contraceptive users, also demands adopting a rights-based
approach and ensuring easy access, choice and good quality
services. In the process of increasing contraceptive use. The
contraceptive method mix in India has been dominated by
female sterilization for a long time. No new contraceptive
method has been added to the national family welfare
program for decades. The Drugs Controller General of India
(DCGI) has approved use of injectable contraceptives in 1994
from the private sector, but still it is not part of the national
program.
Recently some initiatives have been taken to make Depo
Medroxyprogesterone Acetate (DMPA) available through the
public sector in some parts of the country. Two such initiatives
that are well known include (a) Urban Health Initiative (UHI)
project of FHI360 funded by the Bill and Melinda Gates
Foundation (BMGF) which was implemented in public as well
as private health facilities of 11 towns of Uttar Pradesh (UP),
(b) an initiative taken up by the District Collector of
Rajsamand district in Rajasthan, who encouraged district
health officials to introduce DMPA in all rural public health
facilities in the district like Community Health Centers (CHCs),
Primary Health Centers (PHCs) and some of the active Subcente Rs.
The public facilities in UP that participated in the UHI initiative
included DMPA while counseling FP clients on the various
contraceptive methods available in the facility. The counselors
and doctors were oriented by UHI on DMPA. The facilities did
not stock DMPA but it was prescribed to women who desired
to take DMPA and if she came back with the injection the
doctor or the public health nurse of the facility administrated
it. The community mobilization of women living in poor
localities and slums was done by local Non-Governmental

Organizations (NGOs) partnering with UHI in educational and
motivational effort for adopting contraceptive methods. The
NGOs had hired peer educators, each of them responsible for
two thousand population, to promote contraceptives among
couples in reproductive age. The NGO, Janani, partnered with
UHI, organized fixed day clinics at selected spots, where a
doctor and a public health nurse provided the services.

In Rajsamand district, before introducing DMPA, all the
doctors and Lady Health Visitors/Auxiliary Nurse Midwifes/
Public Health Nurses (LHVs/ANMs/PHNs) were trained at the
district headquarter by district officials and a consultant form
Population Health Services India (PHSI), the social marketing
agency and promoter of Khushi brand of DMPA. The LHVs
gave half-day orientation to Accredited Social Health Activists
(ASHAs) on DMPA. The district authorities use their
unrestricted fund to purchase DMPA in bulk at a negotiated
price of Rs. 28 (US$ 0.40) per dose from PHSI. The CHCs and
PHCs purchase DMPA from the district public store as per
their need and charge their clients Rs. 30 (US$ 0.50) per
dose. Thus recovering the unrestricted fund for continued
purchase of DMPA. Initially DMPA was provided only at CHCs
and PHCs and was mostly administrated by LHVs/PHNs. Later,
considering the difficulties faced by women in traveling, DMPA

was made available on a fixed day of the week at some of the
well established Sub-centers and administered by ANM.
Initially it was done under the supervision of LHVs of the area.

OBJECTIVE OF THE STUDY
Present study was undertaken to document these initiatives
taken to provide DMPA through public health facilities, which
in a way could be taken as feasibility study or initial phase of
introducing DMPA in the public sector.

STUDY DESIGN
A multistage sampling procedure was followed and total of
624 DMPA ever users, 316 from three cities of UP (Allahabad,
Lucknow and Aligarh) and 308 from rural areas of Rajsamand
district were interviewed with informed consent obtained from
each of the participants. The sample was sufficient to provide
a statistical valid estimate of responses on the subject.
Besides, in-depth interviews were also conducted with nine
women to get their perspectives on using DMPA. To get
previdus perspectives 38 doctors and 58 paramedics

(LHVs/Nurses/ ANMs) from 21 public health facilities of
Rajsamand and 15 public health facilities of UP were also
interviewed. Additionally, 55 CHWs (33 ASHAs from
Rajsamand and 22 peer educators/counselors from UP) were
also interviewed.

KEY FINDINGS
The study revealed that young married women (mean age of
27 years) were using DMPA for spacing births. The reasons for
women to choose DMPA over other methods are given in
Table 1. About 21 percent women had adopted DMPA after
first child and 18 percent did not have a son. It is perhaps
because of increased access to additional and long acting
spacing method besides IUCD. In the Indian family planning
program spacing methods were less promoted than limiting
methods as indicated by a low use of IUD and other temporary
methods compared to female sterilization. Use of DMPA for
spacing births was more in Rajsamand than UP. This is partly
because, in Rajsamand DMPA was suggested for spacing
while sterilization was suggested to those women who have
achieved their desired family size.
TABLE 1: Women's reasons for choosing DMPA over other
contraceptive methods (percent)*
Reasons

UP

Rajsamand Total

Private & confidential

22

21

21

Nothing to be done daily

45

63

54

Easy to use

39

27

33

Easily available

10

16

13

Effective/reliable/safe

31

30

30

Peer educator/friends advice

40

3

22

Doctors advised

5

0

3

Affordable

5

7

6

Other

12

22

17

316

308

624

Total (N)

*Multiple responses, add up to more than 100.

The following gives a typical quote that was mentioned by
several users revealing factors influencing decision to use
DMPA.
“I used to forget to take pills. I heard that condom
remains inside. So I decided to try injection. The
advantage of injection is that after taking it you need not
take anything for three months. Injection suits me. The
other advantage is that nobody knows about it.” (Woman,
24 years, 3 children, 2 doses, Aligarh, UP)
The study shows that overall women as well as other
stakeholders had positive opinion about DMPA. Out of the 624
ever users of DMPA interviewed, about 31 percent were
current use Rs. Discontinuation was high because of side

“Peer educator has told me about all the methods,
Copper T, pills, condom” (Woman, 23 years, 3 children,
15 doses, Allahabad, UP).

Figure 1: Number of doses taken among current
users of DMPA
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It is important however to note that about half the women
were not told about the side effects indicating improvement in
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Figure 2: Women's knowledge and beliefs on DMPA
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effects. Analysis revealed that discontinuation by second dose
was more than 50 percent both in UP and Rajsamand. The
study also revealed that among the current users of DMPA, 41
percent (and 13 percent among 624 ever user) had taken four
or more doses. The corresponding figure (Figure 1) was
52 percent in UP and 34 percent in Rajsamand.
This is perhaps because of better follow up of first and second
dose acceptors of DMPA were motivated by peer educators in
UP than ASHAs in Rajsamand. The helpline, called ‘Careline’,
operated by Abt Associates also counselled women, which
encouraged them to continue using DMPA (Figure 2).
“I did not find any major problem except that my periods
have been stopped and I gain weight.” (Woman, 24 years,
2 children, 6 doses, Aligarh, UP)
“Those women who don’t have any problems from Depo
and those who want to space births take 3 or more
doses. But women who face side effects or their
husbands find out, or they want more children stop using
it.” (ASHA, Rajsamand, Rajasthan)
Figure 2 shows most women believed that DMPA is a safe (75
to 80 percent) and effective contraceptive method (90
percent in both study sites). They also believed that DMPA is a
good long acting contraceptive method (about 80 percent in
the two sites) for spacing births. Women chose DMPA over
other spacing methods as it saves them from daily
administration of a contraceptive and once taken they do not
have to worry about protection for three months. The
knowledge of interval between two doses was universal. About
half of the women had knowledge about the grace period if
they missed their due date. One-third women (27 percent in
UP and 33 percent in Rajsamand) did not know how long
DMPA could be used continuously. About half the women did
not know about return of fertility after discontinuation.
Quality of services was generally good. At all service delivery
points in both study sites women were given options of
different contraceptive methods to choose from and provider
bias towards DMPA was not found. However, in UP, where the
peer educators were getting incentive for motivating IUD,
DMPA and sterilization, these methods were mentioned more
frequently during counseling than other methods.
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Cost was an issue for more than half of the women,
particularly for those women who faced side effects. In some
cases cost of treatment from side effects was more than the
DMPA. In Rajsamand, cost of the DMPA was lower (Rs. 30,
US$ 0.50) than UP (Rs. 55 to 65, US$ 0.90 to 1) and majority
of the women felt that it could be affordable to most women in
their community. The study revealed that in Rajsamand,
current price of DMPA i.e. Rs. 30 was acceptable to 92
percent of the women so they expressed their willingness to
pay for DMPA. About 73 percent of all the women interviewed
felt that up to Rs. 40, US$ 0.60 is an acceptable price. More
than half of the participants said that they would not be able
to pay if the price of DMPA is more than Rs. 65. Therefore,
increasing the price beyond Rs. 65 could lead to drastic
decline in DMPA use. A similar analysis for UP revealed that
current price (Rs. 55-65) was affordable to most (82%) and an
increase up to Rs. 75, US$ 1.20 would be manageable for 67
percent of the women. Only about 45 percent felt that they
would be willing to pay Rs. 100, US$ 1.60 or more. Overall,
the study indicates that the maximum cost for rural area could
be Rs. 40 and in rural poor localities and in urban slum areas
it could range between Rs. 90 to 100 (US$ 1.40 to 1.60).

Figure 3: Quality of counseling and care
received by women
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percent), easily administered (38 percent doctors and 23
percent paramedics), and keeps contraceptive status
confidential (17 percent doctors and 29 percent paramedics)
(Table 2). Practically all of them were of the view that the
existing amount (Rs. 30 in Rajsamand and about Rs. 65 in
UP) is affordable.

RECOMMENDATIONS

Interviews of the program managers, doctors, paramedics,
and community health workers showed that just as the
beneficiary had expressed, most provide (90 to 95 percent)
strongly felt that DMPA has provided a good additional
contraceptive choice to women. Two-third of doctors and
paramedics strongly supported that DMPA should be included
in the national family welfare program because it is long
acting method and once given women do not have to worry for
three months (53 percent doctors and 74 percent
paramedics), besides they felt that DMPA is safe (25 to 30

•

The study shows that acceptability of the DMPA has
remained good despite many women reporting side
effects. It indicates that DMPA could be introduced safely
without serious health consequences in public sector.

•

Most stakeholders, doctors, and paramedics including the
beneficiary feel that it should be included in the national
family welfare program.

•

A supportive environment to introduce DMPA in the public
sector is needed. It could be created if FOGSI, IMA and
similar medical associations are taken into confidence.
DMPA will be an additional long acting contraceptive
choice to women willing to space between births and do
not want to use IUD or other spacing methods.

•

At the initial stages government may plan to introduce
DMPA at district health facilities and CHCs and then
expand to PHCs and Sub-cente Rs.

•

Like in Rajsamand DMPA could be provided at a cost in
public sector. A cost of Rs. 30 to 40 in rural area and Rs.
60 to 100 in urban facilities could be charged. Women are
willing to pay that if they are made aware of the method
and made easily accessible.

•

Counseling and follow up are important measures to
promote continuation of DMPA use. Women who use 5 to 6
doses may achieve a minimum desired gap of 3 years
between two births.

•

Presently up to 50 percent women are dropping out after
the 2nd dose of DMPA. This indicates that more studies are
required on how to reduce discontinuation rate of DMPA
due to side effects and other myths about the method.

TABLE 2: Attitudes of doctors and nurses (percent)
Attitudes

Doctors
(N=38)

Nurses
(N=58)

Agree that DMPA has provided a
good choice

90

95

Strongly recommended to include
in NFWP

66

64

Key reasons to include in NFWP*
Safe to use

25

30

Effective

13

13

Long acting

53

84

Easy to administer/easy to use

38

23

Private & confidential

16

29

*Multiple responses, add up to more than 100.
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